Organisation paid for research Program year 2025 Source: CMS Open Payments

Precise Clinical Research, Inc

Neither a doctor nor a teaching hospital

Research payments

$155,067

35 payments

Through program year 2025, Precise Clinical Research, Inc is reported as receiving $155,067 in research payments, across 35 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$2,276	1
2024	Research	$15,285	1
2023	Research	$27,962	1
2021	Research	$75,253	16
2020	Research	$27,127	11
2019	Research	$7,164	5

Breakdown

Who paid Research payments · program years 2019–2025

Avanir Pharmaceuticals, Inc. $54,097 9 payments
Sage Therapeutics, Inc. $45,523 3 payments
Eisai Inc. $32,081 15 payments
Corcept Therapeutics $23,367 8 payments

Studies the money was for Research payments · program years 2019–2025

18-Avp-786-207 $54,097 9 payments
217-Clp-118 $45,523 3 payments
A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Proof-of-Concept, Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease $27,081 14 payments
Cort118335-877 $17,367 6 payments
Cort118335-876 $6,000 2 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of the Efficacy and Safety of Lemborexant in Subjects With Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia $5,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.